These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 146533)
1. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Amos HE; Lake BG; Artis J Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533 [TBL] [Abstract][Full Text] [Related]
2. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Behan PO; Behan WM; Zacharias FJ; Nicholls JT Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263 [TBL] [Abstract][Full Text] [Related]
3. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications. Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660 [TBL] [Abstract][Full Text] [Related]
4. Practolol and the safety of other beta blockers. Sutherland DC; Wilson JD N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491 [TBL] [Abstract][Full Text] [Related]
5. Letter: Report on adverse reactions associated with practolol. Proctor CR Med J Aust; 1974 Nov; 2(20):758. PubMed ID: 4280498 [No Abstract] [Full Text] [Related]
6. Letter: Skin reactions to practolol. Wright P Br Med J; 1974 Jun; 2(5918):560. PubMed ID: 4276108 [No Abstract] [Full Text] [Related]
7. Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Amos HE; Brigden WD; McKerron RA Br Med J; 1975 Mar; 1(5958):598-600. PubMed ID: 1092407 [TBL] [Abstract][Full Text] [Related]
9. [Adverse effects of practolol]. Ahonen A Duodecim; 1976; 92(22):1264-5. PubMed ID: 137109 [No Abstract] [Full Text] [Related]
10. Adverse effects of practolol. Nicholls JT Ann Clin Res; 1976 Aug; 8(4):229-31. PubMed ID: 136918 [No Abstract] [Full Text] [Related]
11. [Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)]. Ugeskr Laeger; 1975 Apr; 137(18):1016-7. PubMed ID: 124969 [No Abstract] [Full Text] [Related]
12. Allergic drug reactions: an in vitro model using a mixed function oxidase complex to demonstrate antibodies with specificity for a practolol metabolite. Amos HE; Lake BG; Atkinson HA Clin Allergy; 1977 Sep; 7(5):423-8. PubMed ID: 589777 [TBL] [Abstract][Full Text] [Related]
13. Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Wright P Br Med J; 1975 Mar; 1(5958):595-8. PubMed ID: 1125623 [TBL] [Abstract][Full Text] [Related]
14. [Drug eruptions caused by beta-blockers]. Bonnetblanc JM Ann Med Interne (Paris); 1984; 135(8):639-41. PubMed ID: 6152136 [TBL] [Abstract][Full Text] [Related]
15. A ranked presentation of the MHRA/CSM (Medicines & Health Care Regulatory Agency/Committee on Safety of Medicines) Drug Analysis Print (DAP) data on practolol. Mann RD Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):705-10. PubMed ID: 16088980 [TBL] [Abstract][Full Text] [Related]
16. Eye and skin reactions precede practolol peritonitis. Idänpään-Heikkilä JE; Hästbacka J; Järvinen HJ Lancet; 1977 Dec 24-31; 2(8052-8053):1354. PubMed ID: 74720 [No Abstract] [Full Text] [Related]
18. Cutaneous reactions to practolol. Clinical and histopathological study. Kauppinen K; Niemi KM; Salo OP Ann Clin Res; 1976 Aug; 8(4):232-40. PubMed ID: 136919 [TBL] [Abstract][Full Text] [Related]
19. The elimination of practolol by two human subjects. Dring LG; Gorchein A; Mahgoub AA; Smith RL Br J Clin Pharmacol; 1978 Mar; 5(3):262-5. PubMed ID: 148896 [No Abstract] [Full Text] [Related]
20. Adverse reactions to practolol: some observations on the possible relevence to immune mechanisms. Dick HM; Wright P; Chapman CM; Zacharias FJ; Nicholls JT Allergy; 1978 Apr; 33(2):71-5. PubMed ID: 80139 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]